Mulmit

Cue Biopharma, Inc.Cue Biopharma, Inc.

CUE Nasdaq

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2025-12-3127,466,000-26,552,000-26,602,000-0.28
2024-12-319,287,000-41,500,000-40,674,000-0.72
2023-12-315,490,000-52,149,000-50,733,000-1.11
2022-12-311,245,000-53,225,000-53,010,000-1.49
2021-12-3114,941,370-43,712,073-44,161,175-1.41

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-08-13Meluzio Michael VincentVP, Prin. Accounting Officer13,647
2026-08-13Meluzio Michael VincentVP, Prin. Accounting Officer1,519
2026-08-13Meluzio Michael VincentVP, Prin. Accounting Officer4,106
2026-08-13Meluzio Michael VincentVP, Prin. Accounting Officer3
2026-08-13Meluzio Michael VincentVP, Prin. Accounting Officer13,647
2026-08-13Ray SumitaChief Legal Compliance Officer18,196
2026-08-13Ray SumitaChief Legal Compliance Officer2,383
2026-08-13Ray SumitaChief Legal Compliance Officer6,442
2026-08-13Ray SumitaChief Legal Compliance Officer4
2026-08-13Ray SumitaChief Legal Compliance Officer18,196
2026-08-13Lin Shao-LeeChief Executive Officer5,423
2026-08-13Lin Shao-LeeChief Executive Officer2,375

8-K events

FiledItems
2026-09-21Regulation FD disclosure · Other events · Financial statements and exhibits
2026-08-14Results of operations
2026-08-03Officer or director change
2026-07-10Entry into a material agreement · Unregistered sales of equity securities · Officer or director change · Other events · Financial statements and exhibits
2026-06-03Officer or director change · Submission of matters to a vote · Financial statements and exhibits
2026-06-02Officer or director change · Other events
2026-05-14Financial statements and exhibits
2026-05-01Entry into a material agreement · Unregistered sales of equity securities · Officer or director change · Other events · Financial statements and exhibits
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…

Pharmaceutical Preparations — 같은 업종, 그리고 규모가 비슷한 기업Pharmaceutical Preparations — and other companies of a similar size

SEC가 같은 업종(Pharmaceutical Preparations)으로 분류한 기업이 먼저 오고, 그다음은 제출된 매출로 가까운 순입니다 — 가장 최근 연간 값이며, 연간 값이 없으면 최근 네 분기 합입니다. Companies the SEC assigns to the same industry (Pharmaceutical Preparations) come first, then the nearest by revenue as filed — the latest annual figure, or the last four quarters where no annual one is filed. 순서일 뿐 값이 싸거나 비싸다는 뜻이 아닙니다.Order only — it does not say a company is cheap or expensive.